ACS chemical neuroscience molecule spotlight on Fanapt
- PMID: 22778835
- PMCID: PMC3368683
- DOI: 10.1021/cn100024g
ACS chemical neuroscience molecule spotlight on Fanapt
Abstract
The new mixed dopamaine D(2)/serotonin 5-HT(2A) antagonist, Fanapt (iloperidone), was approved by the FDA on May 6th, 2009 for the treatment of schizophrenia in adults.
References
-
- Vanda Pharmaceuticals Press Release, May 6, 2009.
-
- FDA Press Release, May 6, 2009.
-
- Sainati S. M.; Hubbard J. W.; Chi E.; Grasing K.; Brecher M. B. (1995) Safety, tolerability, and effect of food on the pharmacokinetics of iloperidone (HP 873), a potential atypical antipsychotic. J. Clin. Pharm. 35, 713−720. - PubMed
-
- Titan Pharmaceuticals Press Release, July 28, 2008.
-
- Novartis Press Release, January 11, 2010. www.novartis.com/newsroom/media-releases/en/2010/1371914.shtml.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources